Loading...
Trulieve Cannabis Corp.
TRUL.CN•CNQ
Healthcare
Drug Manufacturers - Specialty & Generic
CA$4.81
CA$-0.13(-2.63%)
Trulieve Cannabis Corp. (TRUL.CN) Financial Performance & Statements
Review Trulieve Cannabis Corp.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
5.07%
↑ 5.07%
Operating Income Growth
144.12%
↑ 144.12%
Net Income Growth
70.56%
↑ 70.56%
Operating Cash Flow Growth
34.50%
↑ 34.50%
Operating Margin
7.16%
↑ 7.16%
Gross Margin
61.11%
↑ 61.11%
Net Profit Margin
-13.90%
↓ 13.90%
ROE
-12.72%
↓ 12.72%
ROIC
3.09%
↑ 3.09%
Trulieve Cannabis Corp. (TRUL.CN) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Trulieve Cannabis Corp. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $301.14M | $284.28M | $303.44M | $297.62M |
| Cost of Revenue | $114.13M | $111.006M | $121.79M | $123.82M |
| Gross Profit | $187.02M | $173.28M | $181.65M | $173.80M |
| Gross Profit Ratio | $0.62 | $0.61 | $0.60 | $0.58 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $157.94M | $148.62M | $102.58M | $101.31M |
| Operating Expenses | $185.71M | $172.66M | $130.66M | $129.06M |
| Total Costs & Expenses | $299.84M | $283.67M | $253.69M | $252.88M |
| Interest Income | $3.18M | $4.20M | $4.04M | $3.26M |
| Interest Expense | $14.62M | $17.46M | $15.45M | $14.67M |
| Depreciation & Amortization | $45.29M | $44.62M | $44.16M | $43.83M |
| EBITDA | $47.002M | $49.24M | $96.11M | $90.44M |
| EBITDA Ratio | $0.16 | $0.17 | $0.32 | $0.30 |
| Operating Income | $1.31M | $618000.00 | $49.75M | $46.10M |
| Operating Income Ratio | $0.004 | $0.002 | $0.16 | $0.15 |
| Other Income/Expenses (Net) | -$14.21M | -$13.46M | -$13.25M | -$14.15M |
| Income Before Tax | -$12.90M | -$12.84M | $36.51M | $31.95M |
| Income Before Tax Ratio | -$0.04 | -$0.05 | $0.12 | $0.11 |
| Income Tax Expense | $47.57M | $47.38M | $47.20M | $55.44M |
| Net Income | -$59.78M | -$60.21M | -$12.03M | -$23.08M |
| Net Income Ratio | -$0.20 | -$0.21 | -$0.04 | -$0.08 |
| EPS | -$0.29 | -$0.32 | -$0.05 | -$0.12 |
| Diluted EPS | -$0.29 | -$0.32 | -$0.05 | -$0.12 |
| Weighted Avg Shares Outstanding | $190.19M | $190.19M | $219.93M | $189.49M |
| Weighted Avg Shares Outstanding (Diluted) | $190.19M | $190.19M | $190.33M | $189.49M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan